EPHS Holdings, Inc. (STNN) financial statements (2021 and earlier)

Company profile

Business Address 5490 NOTRE DAME EST
MONTREAL, QC H1N 2C4
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2011603352868301
Cash and cash equivalents2011603352868301
Other undisclosed current assets3116261010106
Total current assets:2321766053878397
Noncurrent Assets
Operating lease, right-of-use asset100112119
Property, plant and equipment2,8502,87423215312411093
Deposits noncurrent assets141466777
Other undisclosed noncurrent assets  2,583    
Total noncurrent assets:2,9653,0002,94015913111699
TOTAL ASSETS:3,1963,1763,000698210155106
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities42236220995463044
Accounts payable40933119095463044
Interest and dividends payable133119    
Debt894240    
Due to related parties9821321144456
Other undisclosed current liabilities8124    
Total current liabilities:6176304641005034100
Noncurrent Liabilities
Long-term debt and lease obligation1,8711,6361,333    
Long-term debt, excluding current maturities1,8131,5661,254    
Operating lease, liability576979
Other undisclosed noncurrent liabilities177      
Total noncurrent liabilities:2,0481,6361,333    
Other undisclosed liabilities   9   
Total liabilities:2,6642,2651,7971085034100
Stockholders' equity
Stockholders' equity attributable to parent5329111,2035901591217
Common stock7474726359134134
Additional paid in capital4,3164,3162,6621,8391,161937672
Accumulated other comprehensive loss(40)(26)(50)(44)(35)(35)(27)
Accumulated deficit(3,819)(3,454)(1,482)(1,269)(1,026)(914)(772)
Total stockholders' equity:5329111,2035901591217
TOTAL LIABILITIES AND EQUITY:3,1963,1763,000698210155106

Income statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Operating expenses(368)(1,938)(192)(243)(112)(80)(37)
Operating loss:(368)(1,938)(192)(243)(112)(80)(37)
Nonoperating income (expense)3(34)(21)    
Interest and debt expense (34)(19)   812
Other undisclosed loss from continuing operations before equity method investments, income taxes   (44)   
Net income (loss):(364)(2,007)(232)(286)(112)(80)775
Other undisclosed net income (loss) attributable to parent 341944  (812)
Net loss available to common stockholders, diluted:(364)(1,973)(213)(243)(112)(80)(37)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income (loss):(364)(2,007)(232)(286)(112)(80)775
Other comprehensive income (loss)(14)24(6)(9)0(3)(6)
Comprehensive income (loss):(379)(1,983)(238)(296)(112)(84)770
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 341944  (812)
Comprehensive loss, net of tax, attributable to parent:(379)(1,948)(219)(252)(112)(84)(42)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: